Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Neuronetics Inc (STIM)

Neuronetics Inc (STIM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Neuronetics: Q1 Earnings Snapshot

Neuronetics: Q1 Earnings Snapshot

STIM : 2.08 (-4.59%)
Neuronetics: Q4 Earnings Snapshot

Neuronetics: Q4 Earnings Snapshot

STIM : 2.08 (-4.59%)
Neuronetics: Q3 Earnings Snapshot

Neuronetics: Q3 Earnings Snapshot

STIM : 2.08 (-4.59%)
Neuronetics: Q2 Earnings Snapshot

Neuronetics: Q2 Earnings Snapshot

STIM : 2.08 (-4.59%)
Neuronetics (STIM) Reports Q1 Loss, Tops Revenue Estimates

Neuronetics (STIM) delivered earnings and revenue surprises of 2.56% and 2.85%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

STIM : 2.08 (-4.59%)
SIEN : 0.1740 (-18.69%)
Neuronetics: Q1 Earnings Snapshot

Neuronetics: Q1 Earnings Snapshot

STIM : 2.08 (-4.59%)
Neuronetics (STIM) Reports Q4 Loss, Tops Revenue Estimates

Neuronetics (STIM) delivered earnings and revenue surprises of 30.23% and 9.76%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

STIM : 2.08 (-4.59%)
AWH : 2.22 (-3.06%)
Neuronetics: Q4 Earnings Snapshot

Neuronetics: Q4 Earnings Snapshot

STIM : 2.08 (-4.59%)
5 Winning Medical Product Stocks That Still Have Room to Run

Despite ongoing macro challenges, medical product stocks like Cardinal Health (CAH), TransMedics Group (TMDX), Olink Holding (OLK), Silk Road Medical (SILK) and Neuronetics (STIM) are likely to gain from...

CAH : 94.75 (-1.70%)
STIM : 2.08 (-4.59%)
SILK : 21.35 (-2.64%)
TMDX : 142.86 (+1.83%)
OLK : 24.02 (+0.21%)
Is Neuronetics (STIM) Stock Outpacing Its Medical Peers This Year?

Here is how Neuronetics (STIM) and Cabaletta Bio, Inc. (CABA) have performed compared to their sector so far this year.

STIM : 2.08 (-4.59%)
CABA : 10.67 (-2.29%)

Barchart Exclusives

Should Nvidia Consider Paying a Special Dividend in 2024 to Reward Shareholders?
Nvidia's dividend hasn't kept pace with its earnings growth, and after accounting for the steep rise in its share price, the company's dividend yield is a mere 0.038%. Should NVDA consider a special dividend in 2024 to reward shareholders? Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar